News Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Real-time Estimate Cboe Europe Other stock markets 08:28:21 15/05/2026 BST			5-day change	1st Jan Change
119.30 ^GBX	-3.48%		+6.28%	-6.39%

04-20	Roadside Real Estate CEO buys after Hoch purchase	AN
04-15	Cepheid and Oxford Nanopore Technologies Expand Partnership for Infectious Disease Research Collaboration	CI

All News

Mentions Relevance

05-01	Oxford Nanopore Technologies : Proxy Form for 2026 AGM	PU
04-15	Cepheid and Oxford Nanopore Technologies Expand Partnership for Infectious Disease Research Collaboration	CI
03-17	Oxford Nanopore & A.D.A.M. Innovations partner to advance genomic medicine in Japan	RE
03-17	Oxford Nanopore Technologies And A.D.A.M. Innovations Announce International Collaboration To Accelerate Advanced Genomic Medicine In Japan	CI
03-11	Oxford Nanopore Technologies plc Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 03:30 PM
03-10	Oxford Nanopore Technologies plc Announces Termination of Dr Gurdial Singh Sanghera as Director, Effective March 2, 2026	CI
03-03	Oxford Nanopore chair Tatton-Brown buys GBP100,000 in shares	AN
03-02	Oxford Nanopore Technologies plc Provides Earnings Guidance for the Year 2026	CI
03-02	Oxford Nanopore Technologies plc, 2025 Earnings Call, Mar 02, 2026
03-02	Oxford Nanopore shares fall as revenue grows in 2025	AN
03-02	Oxford Nanopore Technologies plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-02	UK's Oxford Nanopore shares fall on medium-term revenue growth forecast cut	RE
03-02	Oxford Nanopore Technologies' FY25 Loss Shrinks; Revenue Rises	MT
03-02	Earnings Flash (ONT.L) Oxford Nanopore Technologies plc Reports FY25 Revenue GBP223.9M	MT
02-27	Oxford Nanopore Technologies says trial set for 2027 to adjudicate MGI Australia's defenses	RE
02-03	UK, Japan Ink Life Sciences, Quantum, Connectivity Partnership Deals	MT
01-13	Oxford Nanopore Technologies plc Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 02:15 PM
01-12	Oxford Nanopore Receives Regulatory Approval for Its First Diagnostic Device in the UK and Europe	CI
01-12	Oxford Nanopore Technologies plc Provides Earnings Guidance for the Full Year 2025	CI
01-12	Oxford Nanopore Expects FY25 Revenue Growth Slightly Ahead of Guidance	MT
01-12	Oxford Nanopore Technologies expects full year revenue growth slightly ahead of guidance	RE
01-08	Stifel Upgrades Oxford Nanopore Technologies to Hold, Raises PT	MT
12-08	Oxford Nanopore Technologies plc Announces Chief Executive Officer Changes, Effective March 2, 2026	CI
12-08	Oxford Nanopore Technologies Names New CEO	MT
12-08	Oxford Nanopore Technologies appoints Francis Van Parys as CEO	RE